You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

estrogen receptor-positive/human epidermal growth factor receptor 2 negative (ER /HER2-)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Sarasota, Nashville (AC699)

Recruiting
  • Breast Cancer
  • Sarasota, Florida
  • +1 more
Jan 3, 2023

Breast Cancer Trial in Denver, Sarasota, Nashville (AC682)

Recruiting
  • Breast Cancer
  • Denver, Colorado
  • +4 more
Dec 12, 2022

Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

Recruiting
  • Hormone Receptor Positive HER-2 Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jun 12, 2023

Breast Tumors Trial in Chuo Ku, Koto-Ku (H3B-6545, Antihistamine)

Active, not recruiting
  • Breast Neoplasms
  • Chuo Ku, Japan
  • +1 more
Dec 19, 2022

Breast Cancer, Breast Cancer, Early-Onset Trial (Giredestrant, Tamoxifen)

Not yet recruiting
  • Breast Cancer
  • Breast Cancer, Early-Onset
  • (no location specified)
Jan 18, 2023

Advanced or Metastatic Breast Cancer Trial in Nashville (AND019 PO QD)

Not yet recruiting
  • Advanced or Metastatic Breast Cancer
  • AND019 PO QD
  • Nashville, Tennessee
    Sarah Cannon Research Institute
Jul 19, 2022

Breast Cancer Trial in United States (ARV-471, ARV-471 in combination with palbociclib (IBRANCE®))

Recruiting
  • Breast Cancer
  • ARV-471
  • ARV-471 in combination with palbociclib (IBRANCE®)
  • Palo Alto, California
  • +16 more
Jan 30, 2023

Breast Cancer Trial ([68Ga]Ga-NeoB, [177Lu]Lu-NeoB, Ribociclib)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
May 22, 2023

Breast Cancer, Estrogen Receptor-positive Breast Cancer Trial in Charlottesville (Aspirin, Tamoxifen Pill, Doxorubicin)

Withdrawn
  • Breast Cancer
  • Estrogen Receptor-positive Breast Cancer
  • Charlottesville, Virginia
    University of Virginia
Nov 12, 2021

Estrogen Receptor Positive Breast Cancer Trial in Houston, Sugar Land (TAK-228, Tamoxifen)

Completed
Has Results
  • Estrogen Receptor Positive Breast Cancer
  • Houston, Texas
  • +2 more
Aug 27, 2021

Breast Cancer Trial in Orange City (ARV-471 (PF-07850327), Palbociclib, Letrozole)

Recruiting
  • Breast Cancer
  • ARV-471 (PF-07850327)
  • +2 more
  • Orange City, Florida
    Mid Florida Hematology and Oncology Center
Jun 8, 2023

Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Trial (Giredestrant, Fulvestrant, Abemaciclib)

Not yet recruiting
  • Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
  • (no location specified)
Sep 26, 2023

Older Women With ER Positive, HER2 Negative Early Breast Cancer

Enrolling by invitation
  • Breast Cancer Female
  • Translational study
  • Sutton, United Kingdom
    The Royal Marsden NHS Foundation Trust
Feb 8, 2023

HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)

Recruiting
  • HR+/HER2- Advanced Breast Cancer
  • Targeted Therapy
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Aug 1, 2023

Breast Cancer Invasive Trial (pyrotinib)

Not yet recruiting
  • Breast Cancer Invasive
  • (no location specified)
Jun 18, 2023

Breast Cancer Trial in Beijing, Zhengzhou, Changsha (EG017)

Not yet recruiting
  • Breast Cancer
  • Beijing, Benjing, China
  • +2 more
Dec 30, 2022

Breast Cancer Trial in New York (core needle biopsy, blood draw)

Recruiting
  • Breast Cancer
  • core needle biopsy
  • blood draw
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Nov 9, 2023

Locally Advanced or Unresectable Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Marietta, East Brunswick (Sacituzumab

Recruiting
  • Locally Advanced or Unresectable Metastatic Breast Cancer
  • Stage IV Breast Cancer
  • Sacituzumab Govitecan-hziy
  • +3 more
  • Marietta, Georgia
  • +1 more
Apr 21, 2023

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Ocala (Samuraciclib, Fulvestrant)

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Ocala, Florida
    Ocala Oncology Center PL DBA Florida Cancer Affiliates
Jul 19, 2023

Estrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast

Terminated
Has Results
  • Estrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast Cancer
  • Phoenix, Arizona
  • +39 more
Jun 21, 2022

Breast Tumors Trial in Japan (E7090, Fulvestrant, Exemestane)

Recruiting
  • Breast Neoplasms
  • Nagoya, Aichi, Japan
  • +10 more
Nov 11, 2022

Metastatic Breast Cancer Trial (Elacestrant)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Oct 24, 2022

Breast Cancer Stage II Trial in Xi'an (Anlotinib)

Recruiting
  • Breast Cancer Stage II
  • Xi'an, Shannxi Province, China
    Xijing Hospital Affiliated to Air Force Military Medical Univers
Sep 25, 2022

ER+, HER2-, Metastatic Breast Cancer Trial in China (AZD9833, AZD9833 with palbociclib, AZD9833 with everolimus)

Recruiting
  • ER+, HER2-, Metastatic Breast Cancer
  • Beijing, China
  • +5 more
Jan 13, 2023

Breast Cancer Trial (Tucatinib, Doxil)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Feb 17, 2023